Bsivo enters Samsung Medical Center after Severance and Seoul National University Hospital

Published: 2018-04-06 16:28:21

Updated: 2018-04-06 16:28:21

‘Besivo Tab,’ an Ildong Pharmaceutical’s new chronic hepatitis B treatment, landed in Samsung Medical Center.

‘Besivo’ is increasing a chance to enlarge its market by entering major general hospitals from Severance Hospital, Seoul National University Hospital to Samsung Medical Center.

According to the industry concerned, Samsung Medical Center recently approved use of Ildong Pharmaceutical’s...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.